Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008450HBVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS10034714HBVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS20027526HPVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44009999HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44012786HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44033742HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44000630HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TCGA Plot Options
Drug Information
GeneCHRNA7
DrugBank IDDB00674
Drug NameGalantamine
Target IDBE0002341
UniProt IDP36544
Regulation Typeallosteric modulator
PubMed IDs10971048; 12481195; 12177686; 21062106; 11172080
CitationsLilienfeld S, Parys W: Galantamine: additional benefits to patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2000 Sep;11 Suppl 1:19-27.@@Woodruff-Pak DS, Lander C, Geerts H: Nicotinic cholinergic modulation: galantamine as a prototype. CNS Drug Rev. 2002 Winter;8(4):405-26.@@Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. CNS Drug Rev. 2002 Summer;8(2):159-76.@@Ludwig J, Hoffle-Maas A, Samochocki M, Luttmann E, Albuquerque EX, Fels G, Maelicke A: Localization by site-directed mutagenesis of a galantamine binding site on alpha7 nicotinic acetylcholine receptor extracellular domain. J Recept Signal Transduct Res. 2010 Dec;30(6):469-83. doi: 10.3109/10799893.2010.505239. Epub 2010 Nov 9.@@Woodruff-Pak DS, Vogel RW 3rd, Wenk GL: Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2089-94. Epub 2001 Feb 6.
GroupsApproved
Direct ClassificationGalanthamine-type amaryllidaceae alkaloids
SMILES[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Pathways
PharmGKBPA449726
ChEMBLCHEMBL659